ÂÜÀòÂÒÂ×

Max Johnston currently serves as a Non Executive Director at Neurotech Pharmaceuticals, Inc. since May 2024 and at INOVIQ Ltd since June 2019. Prior to these roles, Max held several significant positions including Non Executive Director at Tissue Repair from November 2021 to May 2024, and at Medical Developments International from October 2012 to November 2022, where also acted as Interim CEO. Additional leadership roles include Interim Chief Executive Officer at PolyNovo Limited from November 2021 to August 2022, Non Executive Chairman at AusCann from January 2020 to February 2022, and Non Executive Director at PolyNovo Limited from May 2014 to November 2020. Max has also contributed as a Non Executive Director at CannPal Animal Therapeutics from October 2017 to September 2020 and at Prolife Foods Ltd. from November 2016 to July 2020, along with a position on the Advisory Board of Granite Holdings from December 2010 to June 2020. The professional experience spans various aspects of the healthcare industry.